No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00392-020-01653-6.pdf
Reference7 articles.
1. Li B, Yang J, Zhao F et al (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01626-9
2. Chen C, Chen C, Yan JT et al (2020) Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48:E008–E008. https://doi.org/10.3760/cma.j.cn112148-20200225-00123
3. Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994
4. Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30116-8
5. Zhang H, Penninger JM, Li Y et al (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensiv Care Med. https://doi.org/10.1007/s00134-020-05985-9
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Digital economy enables common prosperity: Analysis of mediating and moderating effects based on green finance and environmental pollution;Frontiers in Energy Research;2023-01-05
2. Anesthetic Management of Critical COVID-19 Infection: A Narrative Review of Concepts and Evidence-Based Clinical Practices;Global Journal of Anesthesiology;2022-05-28
3. Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2;Arterial Hypertension;2022-03-31
4. Arterial hypertension – Clinical trials update 2021;Nutrition, Metabolism and Cardiovascular Diseases;2022-01
5. Hypertension in CoViD19;Cardiovascular Complications of COVID-19;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3